US2009047733A1PendingUtilityA1

Avidin-Pseudotyped Viral Vectors and Their Use

Assignee: AIRENNE KARI JUHANIPriority: Mar 12, 2001Filed: Jun 30, 2008Published: Feb 19, 2009
Est. expiryMar 12, 2021(expired)· nominal 20-yr term from priority
C12N 15/86A61K 48/00C12N 2710/14143
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention pertains to an avidin-pseudotyped virus, and especially baculovirus, useful for delivery of foreign genes etc. The present invention also pertains to vectors comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus.

Claims

exact text as granted — not AI-modified
1 . A vector comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus. 
   
   
       2 . The vector according to  claim 1 , comprising one or more of: the origin of replication of the Epstein-Barr virus; a gene capable of expressing Epstein-Barr nuclear antigen I; and a foreign gene which has, or is capable of expressing a peptide, having diagnostic or therapeutic utility. 
   
   
       3 . The vector according to  claim 1 , additionally comprising an effector gene or a marker gene. 
   
   
       4 . The vector according to  claim 2 , additionally comprising an effector gene or a marker gene. 
   
   
       5 . The vector according to  claim 1 , additionally comprising a gene modifying the baculovirus phenotype. 
   
   
       6 . The vector according to  claim 5 , wherein the baculovirus phenotype is modified by pseudotyping. 
   
   
       7 . The vector according to  claim 5 , wherein the modifying gene is under the control of a promoter functional in insect cells. 
   
   
       8 . A baculovirus comprising the elements of:
 i) a vector comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus.   
   
   
       9 . The baculovirus according to  claim 8 , comprising one or more of: the origin of replication of the Epstein-Barr virus; a gene capable of expressing Epstein-Barr nuclear antigen 1; and a foreign gene which has, or is capable of expressing a peptide, having diagnostic or therapeutic utility. 
   
   
       10 . The baculovirus according to  claim 8 , additionally comprising an effector gene or a marker gene. 
   
   
       11 . The baculovirus according to  claim 9 , additionally comprising an effector gene or a marker gene. 
   
   
       12 . The baculovirus according to  claim 8 , additionally comprising a gene modifying the baculovirus phenotype. 
   
   
       13 . The baculovirus according to  claim 12 , wherein the baculovirus phenotype is modified by pseudotyping. 
   
   
       14 . The baculovirus according to  claim 12 , wherein the modifying gene is under the control of a promoter functional in insect cells.

Join the waitlist — get patent alerts

Track US2009047733A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.